Life-extending lung cancer drug approved for use in Scotland



Scotland has become the first part of the UK to approve a new life-extending treatment for the most common form of advanced lung cancer for use on the NHS.
Rates of lung cancer in Scotland are among the highest in the world and the new treatment helps patients live longer and have a better quality of life.
The Scottish Medicines Consortium (SMC) approved the new drug, nivolumab, also known as Opdivo, for use in patients with non-squamous non-small cell lung cancer.
Officials said it can extend the typical eight-month life expectancy by three months.
Figures from 2014 show around 5,300... read more

 
10 October 2016 in Health, Views: 36
Source: Scotsman
Share:
  •  





    News Widget for Webmasters



    Bring Eugene's son back home immediately

    Realtime News

     

    «
    »
    Mo Tu We Th Fr Sa Su
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30 31